Bajaj Healthcare acquires Genrx Pharmaceuticals

08 Apr 2025 Evaluate

Bajaj Healthcare has successfully acquired Genrx Pharmaceuticals (in Liquidation) as a going concern, as per the Sale Certificate dated April 4, 2025, issued by the Official Liquidator. The acquisition, valued at Rs 10.85 crore through a cash consideration, involves 100% control of the target entity.

Bajaj Healthcare mainly focuses on development, manufacturing and supply of Amino Acids, Nutritional Supplements and Active Pharmaceutical Ingredients (API) for Pharmaceutical, Nutraceuticals and Food industries.

Bajaj Healthcare Share Price

346.70 -13.05 (-3.63%)
30-Jan-2026 15:29 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1598.00
Dr. Reddys Lab 1215.70
Cipla 1328.40
Zydus Lifesciences 888.50
Lupin 2150.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×